Marimed (MRMD) Notes Payables (2013 - 2026)

Marimed (MRMD) has reported Notes Payables for 14 consecutive years, with $3.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Notes Payables changed 0.06% year-over-year to $3.4 million in Q2 2026; TTM through Jun 2026 was $3.4 million, a 0.06% change from a year earlier, with the FY2025 full-year figure at $2.6 million, down 50.2% from the prior year.
• Notes Payables was $3.4 million for Q2 2026 at Marimed, up from $3.3 million in the prior quarter.
• Over five years, Notes Payables peaked at $5.1 million in Q4 2024 and troughed at $10000.0 in Q1 2022.
• A 5-year average of $2.4 million and a median of $2.9 million in 2025 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables tumbled 80.84% in 2023 and surged 14237.04% in 2024, its largest moves.
• Over 5 years, Notes Payables stood at $3.8 million in 2022, then plunged by 80.84% to $723000.0 in 2023, then jumped by 608.99% to $5.1 million in 2024, then slumped by 50.2% to $2.6 million in 2025, then surged by 33.84% to $3.4 million in 2026.
• The last three Notes Payables figures came in at $3.4 million (Q2 2026), $3.3 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.